This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Nycomed Gmbh, Takeda Gmbh. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2013
Title: Daniela Hauser: Innovator in Diabetes Treatment
Introduction
Daniela Hauser is a prominent inventor based in Singen, Germany. She has made significant contributions to the field of diabetes treatment, holding 2 patents that focus on innovative uses of Roflumilast.
Latest Patents
Her latest patents include the application of Roflumilast for the treatment of diabetes mellitus type 2. This application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in treating diabetes mellitus type 2. Another patent involves the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and its accompanying disorders. This invention also explores combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for diabetes treatment.
Career Highlights
Throughout her career, Daniela has worked with notable companies such as Nycomed GmbH and Takeda GmbH. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.
Collaborations
Daniela has collaborated with esteemed colleagues, including Hans-Peter Kley and Guido Hanauer, further enhancing her work in the field.
Conclusion
Daniela Hauser's contributions to diabetes treatment through her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile